ZBTB (Zinc finger BTB domain containing) Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Hydroxypropyl-β-cyclodextrin | 128446-35-5 | sc-203461 sc-203461B sc-203461C sc-203461A | 1 g 100 g 500 g 5 g | $52.00 $620.00 $1950.00 $130.00 | 8 | |
Potential Zinc finger BTB domain containing (ZBTB) protein inhibition for multiple myeloma. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide is a natural compound found in the medicinal plant Tripterygium wilfordii (Thunder god vine). It has been reported to inhibit Zinc finger BTB domain containing (ZBTB) protein and has been studied for its potential anti-cancer properties. | ||||||
(–)-Nutlin-3 | 675576-98-4 | sc-222086 sc-222086A | 1 mg 5 mg | $120.00 $215.00 | 2 | |
Inhibition of p53-MDM2 interaction and Zinc finger BTB domain containing (ZBTB) protein. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $61.00 $245.00 $1173.00 | ||
Chidamide is a selective HDAC inhibitor that has been investigated for its effects on Zinc finger BTB domain containing (ZBTB) protein expression and its potential anti-cancer properties. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Panobinostat inhibits Miz-1 activity by altering chromatin structure through increased histone acetylation, thereby impairing Miz-1's access to target gene promoters. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Cisplatin is a chemotherapy drug that has been reported to downregulate Zinc finger BTB domain containing (ZBTB) protein expression in certain cancer cell lines. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $28.00 $37.00 | 18 | |
Indomethacin is a nonsteroidal anti-inflammatory drug (NSAID) that has been reported to downregulate Zinc finger BTB domain containing (ZBTB) protein expression and inhibit its activity. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A is an antibiotic that has been reported to inhibit Zinc finger BTB domain containing (ZBTB) protein expression and has been studied for its potential effects. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Potential Zinc finger BTB domain containing (ZBTB) protein inhibition, anti-cancer activity. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $280.00 | 1 | |
Inhibition of NEDD8-activating enzyme, affects Zinc finger BTB domain containing (ZBTB) protein through protein neddylation regulation. | ||||||